Niazirin

	产品编号	CFN96998
	CAS编号	122001-32-5
	分子式 = 分子量	C₁₄H₁₇NO₅ = 279.29
	产品纯度	>=98%
	物理属性	Powder
	化合物类型	Phenols
	植物来源	The leaves of Moringa oleifera.
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用

提供自定义包装

产品名称	产品编号	CAS编号	包装	QQ客服
Niazirin	CFN96998	122001-32-5	1mg	QQ客服：2159513211
Niazirin	CFN96998	122001-32-5	5mg	QQ客服：2159513211
Niazirin	CFN96998	122001-32-5	10mg	QQ客服：2159513211
Niazirin	CFN96998	122001-32-5	20mg	QQ客服：2159513211

存储与注意事项

1. 在您收到产品后请检查产品。如无问题，请将产品存入冰霜并且样品瓶保持密封，产品可以存放长达24个月（2-8摄氏度）。

2. 只要有可能，产品溶解后，您应该在同一天应用于您的实验。但是，如果您需要提前做预实验，或者需要全部溶解，我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。通常，这些可用于长达两周。使用前，打开样品瓶前，我们建议您将产品平衡至室温至少1小时。

3. 需要更多关于溶解度，使用和处理的建议？请发送电子邮件至：service@chemfaces.com

订购流程

1. 在线订购

请联系我们QQ客服

2. 电话订购

请拨打电话：
027-84237683 或 027-84237783

3. 邮件或传真订购

发送电子邮件到: manager@chemfaces.com 或
发送传真到：027-84254680

提供订购信息

为了方便客户的订购，请需要订购ChemFaces产品的客户，在下单的时候请提供下列信息，以供我们快速为您建立发货信息。

1. 产品编号（CAS No.或产品名称）

2. 发货地址

3. 联系方法 (联系人，电话）

4. 开票抬头 (如果需要发票的客户）

5. 发票地址（发货地址与发票地址不同）

发货时间

1. 付款方式为100%预付款客户，我们将在确认收到货款后当天或1-3个工作日发货。

2. 付款方式为月结的客户，我们承诺在收到订单后当天或1-3个工作日内发货。

3. 如果客户所需要的产品，需要重新生产，我们有权告知客户，交货时间需要延期。

Description:

The Moringa oleifera extract(including niaziridin and Niazirin) can successfully attenuate the development of pulmonary hypertension via direct vasodilatation and a potential increase in antioxidant activity.

In vitro:

Mutat Res. 1999 Apr 6;440(2):181-8.

An antitumor promoter from Moringa oleifera Lam.[Pubmed: 10209341]

In the course of studies on the isolation of bioactive compounds from Philippine plants, the seeds of Moringa oleifera Lam. were examined and from the ethanol extract were isolated the new O-ethyl-4-(alpha-L-rhamnosyloxy)benzyl carbamate (1) together with seven known compounds, 4(alpha-L-rhamnosyloxy)-benzyl isothiocyanate (2), niazimicin (3), Niazirin (4), beta-sitosterol (5), glycerol-1-(9-octadecanoate) (6), 3-O-(6'-O-oleoyl-beta-D-glucopyranosyl)-beta-sitosterol (7), and beta-sitosterol-3-O-beta-D-glucopyranoside (8).
METHODS AND RESULTS:
Four of the isolates (2, 3, 7, and 8), which were obtained in relatively good yields, were tested for their potential antitumor promoting activity using an in vitro assay which tested their inhibitory effects on Epstein-Barr virus-early antigen (EBV-EA) activation in Raji cells induced by the tumor promoter, 12-O-tetradecanoyl-phorbol-13-acetate (TPA). All the tested compounds showed inhibitory activity against EBV-EA activation, with compounds 2, 3 and 8 having shown very significant activities. Based on the in vitro results, niazimicin (3) was further subjected to in vivo test and found to have potent antitumor promoting activity in the two-stage carcinogenesis in mouse skin using 7,12-dimethylbenz(a)anthracene (DMBA) as initiator and TPA as tumor promoter.
CONCLUSIONS:
From these results, niazimicin (3) is proposed to be a potent chemo-preventive agent in chemical carcinogenesis.

In vivo:

Chin J Physiol. 2012 Apr 30;55(2):101-7.

Effects of 2-azafluorenones on phosphatidyl-inositol specific phospholipase C activation in c6 glioma cells.[Pubmed: 22559734 ]

The purpose of this study was to determine the effects of an extract from Moringa oleifera (MO) on the development of monocrotaline (MCT)-induced pulmonary hypertension (PH) in Wistar rats. An ethanol extraction was performed on dried MO leaves, and HPLC analysis identified niaziridin and Niazirin in the extract.
METHODS AND RESULTS:
PH was induced with a single subcutaneous injection of MCT (60 mg/kg) which resulted in increases in pulmonary arterial blood pressure (Ppa) and in thickening of the pulmonary arterial medial layer in the rats. Three weeks after induction, acute administration of the MO extract to the rats decreased Ppa in a dose-dependent manner that reached statistical significance at a dose of 4.5 mg of freeze-dried extract per kg body weight. The reduction in Ppa suggested that the extract directly relaxed the pulmonary arteries. To assay the effects of chronic administration of the MO extract on PH, control, MCT and MCT+MO groups were designated. Rats in the control group received a saline injection; the MCT and MCT+MO groups received MCT to induce PH. During the third week after MCT treatment, the MCT+MO group received daily i.p. injections of the MO extract (4.5 mg of freeze-dried extract/kg of body weight). Compared to the control group, the MCT group had higher Ppa and thicker medial layers in the pulmonary arteries. Chronic treatments with the MO extract reversed the MCT-induced changes. Additionally, the MCT group had a significant elevation in superoxide dismutase activity when normalized by the MO extract treatments.
CONCLUSIONS:
In conclusion, the MO extract successfully attenuated the development of PH via direct vasodilatation and a potential increase in antioxidant activity.

产品名称	产品编号	CAS编号	分子式 = 分子量	位单	联系QQ
2-氨基-1-苯乙醇; 2-Amino-1-phenylethanol	CFN00052	111025-00-4	C₁₅H₁₅NO₂ = 241.29	5mg	QQ客服：1457312923
N-Benzoyl-2-hydroxy-2-phenylethylamine; N-Benzoyl-2-hydroxy-2-phenylethylamine	CFN00053	111059-46-2	C₁₅H₁₅NO₂ = 241.29	5mg	QQ客服：2159513211
Muricatide; Muricatide	CFN00054	111025-01-5	C₁₇H₁₇NO₃ = 283.33	5mg	QQ客服：1457312923
苄胺; Benzylamine	CFN00064	100-46-9	C₇H₉N = 107.15	5mg	QQ客服：2159513211
N-甲基苄胺; N-Methylbenzylamine	CFN00065	103-67-3	C₈H₁₁N = 121.18	5mg	QQ客服：1413575084
2-羟基苄胺; 2-Hydroxybenzylamine	CFN00079	932-30-9	C₇H₉NO = 123.15	20mg	QQ客服：215959384
3-氨甲基苯酚; 3-Hydroxybenzylamine	CFN00080	73604-31-6	C₇H₉NO = 123.15	5mg	QQ客服：1457312923
4-羟基苄胺; 4-Hydroxybenzylamine	CFN00081	696-60-6	C₇H₉NO = 123.15	5mg	QQ客服：215959384
Niazinin; Niazinin	CFN89344	147821-57-6	C₁₅H₂₁NO₆S = 343.39	5mg	QQ客服：1457312923
Niazimicin; Niazimicin	CFN89363	147821-49-6	C₁₆H₂₃NO₆S = 357.42	5mg	QQ客服：1413575084

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	3.5805 mL	17.9025 mL	35.8051 mL	71.6102 mL	89.5127 mL
5 mM	0.7161 mL	3.5805 mL	7.161 mL	14.322 mL	17.9025 mL
10 mM	0.3581 mL	1.7903 mL	3.5805 mL	7.161 mL	8.9513 mL
50 mM	0.0716 mL	0.3581 mL	0.7161 mL	1.4322 mL	1.7903 mL
100 mM	0.0358 mL	0.179 mL	0.3581 mL	0.7161 mL	0.8951 mL

Niazirin

Niazirin

信息支持

联系方式